Table 2 Three-year clinical outcomes in patients with CMM stratified by OSA Status
From: Impact of obstructive sleep apnea on prognosis of patients with cardiometabolic multimorbidity
Variables | CMM (n = 723) | Non-CMM (n = 1204) | ||||
|---|---|---|---|---|---|---|
OSA (n = 383) | Non-OSA (n = 340) | P value | OSA (n = 631) | Non-OSA (n = 573) | P value | |
MACCE | 99 (34.7) | 61 (23.7) | 0.004 | 107 (22.7) | 93 (21.3) | 0.572 |
Cardiovascular death | 9 (3.4) | 8 (3.3) | 0.950 | 7 (1.6) | 5 (1.2) | 0.651 |
Myocardial infarction | 10 (3.7) | 5 (2.1) | 0.231 | 19 (4.2) | 10 (2.4) | 0.129 |
Stroke | 16 (5.9) | 12 (4.9) | 0.546 | 6 (1.3) | 6 (1.4) | 0.919 |
Hospitalization for unstable angina | 63 (22.7) | 41 (16.3) | 0.049 | 79 (17.0) | 71 (16.4) | 0.761 |
Hospitalization for heart failure | 7 (2.6) | 3 (1.2) | 0.240 | 2 (0.4) | 4 (1.0) | 0.384 |
Ischemia-driven revascularization | 34 (12.5) | 26 (10.4) | 0.444 | 50 (10.8) | 36 (8.5) | 0.210 |
Cardiac events§ | 85 (30.3) | 53 (20.9) | 0.011 | 102 (21.7) | 87 (20.0) | 0.485 |
All-cause death | 12 (4.5) | 14 (5.7) | 0.564 | 8 (1.8) | 8 (1.9) | 0.883 |
All repeat revascularization | 49 (17.7) | 34 (13.5) | 0.175 | 70 (15.0) | 59 (13.6) | 0.561 |
PCI | 46 (16.6) | 33 (13.1) | 0.247 | 65 (14.0) | 53 (12.3) | 0.445 |
CABG | 3 (1.1) | 1 (0.4) | 0.342 | 5 (1.1) | 6 (1.4) | 0.655 |
Target vessel revascularization | 24 (8.8) | 20 (8.1) | 0.711 | 34 (7.4) | 27 (6.4) | 0.507 |
Non-target vessel revascularization | 35 (12.7) | 16 (6.5) | 0.015 | 46 (10.0) | 37 (8.7) | 0.527 |